A Leader in First-in-Patient Studies
State-of-the-Art Research Unit
Contact us now
MHRA Phase 1 Accredited
Contact us now
Intelligent Recruitment Strategies
to Facilitate Patient Selections
Please call our recruitment manager for direct access to feasibility
Contact us now
Previous
Next

A LEADER IN FIRST-IN-PATIENT STUDIES

Phase 1 Clinical Trials

The MEU is a UK leader in First in Man studies. We have considerable expertise in SAD and MAD trials. The emergence of hybrid designs, including patient cohorts, has allowed the MEU to provide a complete solution for clients seeking a single site solution for their Phase 1 programme.

Therapeutic Areas

The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase 1 studies in many other therapeutic areas.

Facilities

State-of-the-art, hospital-based facilities including 36 inpatient beds with cardiac and telemetry monitoring, a pharmacy, clinical assessment suite, bronchoscopy unit and numerous outpatient/consultant rooms.

Recruitment

Contact us today to sense-check your protocol synopsis against our ICARUS phenotyped database of over 17,000 clinical trial volunteers. We can run inclusion/exclusion criteria in minutes, instantly checking the phenotyped data across multiple therapeutic fields.

MEASURING EXCELLENCE WITHIN A PHASE 1 TRIALS UNIT

Phase 1 Accreditation

The MEU is an MHRA Phase 1 accredited unit and has been part of the scheme since its inception. This ensures that our studies are conducted to the highest standards in terms of both safety and quality.

MEU have held MHRA Phase 1 accreditation since July 2009 with the latest inspection being 2018

Inspection results

Our last five inspections, shown below, show 10 Years of No Criticals and, No Majors findings:

A leader in First-In-Patient studies for over twenty years

Latest News

Latest News

Queen’s Award for Enterprise in International Trade 2020

During these challenging times, it’s important to celebrate good news and we are delighted to announce today that we have been honoured with The Queen’s Award for Enterprise in International Trade! The awards have been announced today, on Her Majesty The Queen’s 94th birthday, and The MEU is one of the 220 organisations nationally to […]

Latest News

The 3rd Cystic Fibrosis Clinical Trials Meeting: Improving Access for All

We’re looking forward to attending The 3rd Cystic Fibrosis Clinical Trials Meeting: Improving Access for All in Nottingham later this month. The event proposes a number of highly regarded UK and international speakers, and has been developed by the scientific committee to cover a broad range of stakeholders and to respond to the needs of […]

© 2020 Medicines Evaluation Unit · All rights reserved · Email Login